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Abstract
Background: Calmodulin (CaM) is a ubiquitously expressed calcium sensor that engages in regulatory interactions with a
large number of cellular proteins. Previously, a unique mode of CaM target recognition has been observed in the crystal
structure of a complex between CaM and the CaM-binding domain of calcineurin A.
Methodology/Principal Findings: We have solved a high-resolution crystal structure of a complex between CaM and the
CaM-binding domain of calcineurin A in a novel crystal form, which shows a dimeric assembly of calmodulin, as observed
before in the crystal state. We note that the conformation of CaM in this complex is very similar to that of unliganded CaM,
and a detailed analysis revels that the CaM-binding motif in calcineurin A is of a novel ‘1-11’ type. However, using small-
angle X-ray scattering (SAXS), we show that the complex is fully monomeric in solution, and a structure of a canonically
collapsed CaM-peptide complex can easily be fitted into the SAXS data. This result is also supported by size exclusion
chromatography, where the addition of the ligand peptide decreases the apparent size of CaM. In addition, we studied the
energetics of binding by isothermal titration calorimetry and found them to closely resemble those observed previously for
ligand peptides from CaM-dependent kinases.
Conclusions/Significance: Our results implicate that CaM can also form a complex with the CaM-binding domain of
calcineurin in a 1:1 stoichiometry, in addition to the previously observed 2:2 arrangement in the crystal state. At the
structural level, going from 2:2 association to two 1:1 complexes will require domain swapping in CaM, accompanied by the
characteristic bending of the central linker helix between the two lobes of CaM.
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Introduction
Calmodulin (CaM) is a calcium-dependent regulatory protein,
able to interact with a plethora of target proteins having diverse
functions [1]. CaM consists of N- and C-terminal lobes and a central
helix. Bending of the central helix is instrumental to conformational
changes occurring during target protein recognition. Upon calcium
binding to the four EF-hands of CaM, a hydrophobic pocket opens
in each of the two lobes of CaM, which then interact with large
hydrophobic or aromatic residues from the target sequence.
Originally, the binding of CaM to its target sequence was shown
to involve the collapse of CaM around the peptide [2–4]; the idea
was proven by studies on peptides from CaM-dependent protein
kinases (CaMKs) as well as from other proteins [5,6]. The
canonical binding mode is antiparallel, such that the N-terminal
half of the peptide interacts with the C-terminal lobe of CaM and
vice versa. During recent years, a growing number of non-classical
modes of binding for CaM towards its target peptides have been
detected [1,7–11]. Such modes involve differences in both the
conformation of CaM, which may also exist in an extended
conformation in a complex, and the stoichiometry of the formed
complex, not always being 1:1.
One example of a non-classical mode of CaM-peptide interaction
has been suggested in the case of the calmodulin-binding domain
(CBD) of calcineurin A (CnA). Crystal structures have indicated the
formation of a 2:2 complex between CaM and the CnA-CBD. The
same kind of complex in the crystal state was observed both when
using a CaM-CnA-CBD fusion protein [12] and when cocrystalliz-
ing CaM with a synthetic CnA-CBD peptide [13]. Computational
studies have, in addition, suggested that the peptides in the complex
have a role in stabilizing the 2:2 association of CaM [14]. Small-
angle scattering experiments with longer peptides have, however,
been indicative of a 1:1 complex [15].
Here, we have carried out further in-depth studies on the CaM
complex with CnA-CBD. A high-resolution crystal structure of the
complex was determined, again showing the 2:2 complex seen
PLoS ONE | www.plosone.org 1 April 2009 | Volume 4 | Issue 4 | e5402before, and extensive disorder is seen in the hydrophobic pockets
of CaM that interact with the peptide. However, other methods
provide results that are in clear disagreement with the crystal
structures. Size exclusion chromatography indicates that in
solution, the complex has a smaller radius than unliganded
CaM, excluding the possibility of a 2:2 complex. Most important-
ly, synchrotron small-angle X-ray scattering (SAXS) data indicate
the presence of a 1:1 complex, which, in ab initio modelling, shows
a highly similar conformation to the canonical collapsed mode of
CaM-peptide interaction, seen also for peptides from CaMKs.
The energetics of binding, determined by calorimetry, also
resemble those seen for the canonical mode of binding.
Results and Discussion
The high-resolution crystal structure of the complex
The complex between CaM and the CnA-CBD peptide was
crystallized in a novel space group, comparing to the two earlier
crystal structures of this complex [12,13]. Synchrotron X-ray
diffraction data allowed us to solve and refine the structure of the
complex at 1.45-A ˚ resolution (Table 1), much higher than
previously obtained for the CaM-CnA-CBD complex (between
1.86 and 2.6 A ˚). It should also be mentioned that only one CaM-
peptide complex has been studied at a higher resolution to date:
the complex between CaM and a CBD peptide from smooth
muscle myosin light chain kinase (PDB entry 2o5g, unpublished).
The overall conformation of the CaM-CnA-CBD complex seen in
the crystal is the same as in the earlier structures of this complex;
most notably, the complex is formed by 2:2 association, such that
CaM forms an X-shaped dimer (Figure 1A). The two peptides in
the complex are sandwiched each between the N-terminal lobe
from one CaM molecule and the C-terminal lobe from another
CaM molecule. The binding mode is somewhat unexpected; while
the ‘1-10’ and ‘1-14’ modes are the most common for CaM ligands
(the numbering originating from the relative positions in the
primary sequence of large hydrophobic residues that bind to the
two hydrophobic pockets of CaM), in the case of the CnA-CBD,
the binding mode is ‘1-11’. The residues buried in the
hydrophobic pockets are, namely, Ile400 and Phe410. The
calmodulin target database [16] lists the CnA-CBD as a member
of the motif ‘1-5-8-14’, which - based on the current high-
resolution structure - is wrong. A comparison to the conformation
of a collapsed CaM-peptide complex indicates that the peptide
conformation, with respect to the two CaM lobes interacting with
it, is also distinct in the CaM-CnA-CBD complex (Figure 1B).
Interestingly, a recent study pointed out that the oxidation of
Met406 in the CBD of CnA can lower the affinity towards CaM
and prevent calcineurin activation [17]. In the structure, Met406
is close to Phe410, interacting closely with the edge of the N-
terminal hydrophobic pocket of CaM, where there are no
potential hydrogen bond donors. Thus, the oxidation of Met406
may both affect the conformation of Phe410 and lower the affinity
by bringing a hydrophilic oxygen atom into the highly
hydrophobic environment.
At the middle of the X-shaped 2:2 complex, between the two
central helices, a network of salt bridges exists, formed by, for
example, Arg408 from both peptides and Glu80 and Glu83 from
both CaM molecules. The side chains in this salt bridge network
are rather disordered, indicating they are probably not forming a
rigid network supporting the extended conformation (Figure 1C).
The high resolution of the diffraction data allows the
examination of the fine details of peptide recognition in the
complex. It is notable that both of the hydrophobic pockets of
CaM are relatively disordered, many of the Phe and Met residues
being present in a double conformation despite the presence of
bound peptide (Figure 1D,E). Also residues in the peptide are
rather disordered; these observations bring into question the
suggested triggering role of the peptide in the formation of a 2:2
complex [14]. It should also be noted that the B-factors in the
crystal are distributed such that low B-factors are also seen at the
exterior of the complex, being involved in crystal contacts, while,
as mentioned above, there exists disorder in the peptide and the
peptide-binding site. Thus, it is possible that the 2:2 complex is, at
least partially, stabilized by the crystal contacts.
Superposition of the N-terminal half of monomer A from the
current and earlier structures indicates flexibility for the central
linker, which in all cases is still folded as a long helix. At the other
end of the complex, the entire lobe of CaM has moved by
approximately 5 A ˚ between some of the structures (not shown).
Further superposition analysis indicates also that the intermolec-
ular linkage between the two extended CaM molecules is not tight.
DynDom analysis of domain motions [18] between each CaM
chain in the asymmetric unit of our new structure and the previous
structures of the complex indicates that the observed conforma-
tional change between different liganded forms can mainly be
explained by a 15-degree rotation that occurs between residues
80–90, i.e. in the C-terminal half of the linker helix (Table S1). In
all cases where dynamic domains were identified, there were two
domains found. In contrast, comparing the complex to unliganded
CaM, there are either 2 or 3 moving domains, depending on
which chains are used; the main bending region is at residue 90, at
the end of the linker helix, but another one is around residue 60, at
the beginning of this helix. Thus, it seems that in the CaM-CnA-
CBD complex, CaM is mostly in the unliganded conformation up
to residue 90, after which the C-terminal lobe has turned
Table 1. Crystallographic data collection and structure
solution.
Data collection
Resolution range (A ˚) 20.0-1.45 (1.49-1.45)
Space group P21
Unit cell dimensions
a, b, c (A ˚) 65.3, 81.3, 71.2
a, b, c (u) 90.0, 111.3, 90.0
Completeness (%) 98.9 (98.7)
Rsym (%) 6.5 (57.5)
Redundancy 4.0 (3.6)
,I/s(I). 8.9 (2.7)
Refinement
Resolution range (A ˚) 10.0-1.45
Rcryst (%) 18.4
Rfree (%) 21.6
Rmsd bond lengths (A ˚) 0.020
Rmsd bond angles (u) 1.8
Rmsd B factors of bonded atoms
(main chain, side chain) (A ˚2)
2.5, 4.8
Ramachandran plot (%)
Preferred 97.8
Allowed 2.2
Outliers 0.0
doi:10.1371/journal.pone.0005402.t001
Structure of CaM-CnA Complex
PLoS ONE | www.plosone.org 2 April 2009 | Volume 4 | Issue 4 | e5402Figure 1. Crystal structure of the CaM-CnA-CBD complex. A. Overall structure. The two peptides are shown in red and the two monomers of
CaM in yellow and orange. The N termini of both CaM monomers point to the left. B. Comparison to a classical collapsed structure of a CaM-peptide
complex (PDB entry 1WRZ). The superposition was carried out using the N-terminal lobe of CaM (to the right on this view). The colours for the CaM-
CnA-CBD complex are as in A, and in the collapsed conformation, CaM is shown in green and the peptide in blue. The location of the hinge, related to
the formation of the collapsed conformation, at the middle of the long linker helix is clearly visible. The N and C termini of the collapsed structure are
labeled. C. The central part of the X-shaped complex contains a network of salt bridges. Most of the residues involved are mobile in the crystal and
Structure of CaM-CnA Complex
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same hinge is observed between the different CnA-CBD
complexes, it can be postulated that formation of the complex
mainly involves bending at a single site on CaM, and that the
bending is not constant in the complex, but significant flexibility
exists also in the crystal state. When comparing unliganded CaM
to the collapsed conformation, on the other hand, a hinge is seen
at the middle of the central helix, at the region containing residues
80–81 (see Figure 1B).
Energetics of the interaction
The binding of the CnA-CBD to CaM was analyzed by
isothermal titration calorimetry (ITC), in order to get an accurate
estimate of the affinity and thermodynamic parameters of binding
(Figure 2A, Table 2). The affinity of CaM towards the peptide is
sub-micromolar. The binding stoichiometry from ITC is clearly
1:1, but it should be noted that a 2:2 complex is by no means
excluded by this result, since such details are indistinguishable in
this experiment. The experiment was carried out at two different
temperatures, allowing the estimation of the magnitude of the heat
capacity. The estimated heat capacity, 20.8 kcal/mol/K, is in the
same range as previously observed for collapsed CaM-peptide
complexes [19], strongly suggesting a collapsed structure for the
complex.
Size exclusion chromatography
The solution properties of CaM alone and in complex with the
CnA-CBD were initially analyzed with size exclusion chromatog-
raphy. Unliganded CaM, due to its elongated dumbbell shape,
runs at an apparent molecular weight of 25–30 kDa. If the
complex has a structure similar to that seen in the crystal structure,
one would expect it to elute from the column faster than CaM
alone; the 2:2 arrangement is made of two elongated CaM
molecules, which sandwich two CnA-CBD peptides between
them. Thus, the expected hydrodynamic radius for the 2:2
complex would be significantly higher than for CaM. However,
the complex actually elutes from gel filtration later than CaM
(Figure 2B, Figure S1), suggesting a smaller hydrodynamic radius;
similar behaviour was observed earlier with a peptide from myelin
basic protein [9]. This implies both that the complex is not 2:2 but
1:1 in solution, and that CaM undergoes a conformational change
in the presence of the peptide that decreases its hydrodynamic
radius. The latter options both are compatible with the classical
collapse of CaM around a target peptide.
have been built in two conformations. The labels for acidic residues from CaM are in red and those for basic residues in the peptide in blue. D. The
environment of the N-terminal anchoring residue Ile400 from the peptide in the C-terminal hydrophobic pocket of CaM. Note that all CaM residues
forming the pocket are in double conformations. The structure is shown from two different monomers in the asymmetric unit of the structure (white
and orange colours). E. The environment of the C-terminal anchoring residue Phe410 from the peptide in the N-terminal hydrophobic pocket of CaM.
All 5 methionine residues in the pocket are disordered, and Phe410 is also in a double conformation. Colouring as in D. F. Comparison to the
unliganded structure. The stereo view indicates that the structure of the CaM monomer in the complex (orange) is highly similar to that of
unliganded CaM (blue).
doi:10.1371/journal.pone.0005402.g001
Figure 2. Characterization of the complex by calorimetry and size exclusion chromatography. A. ITC. Top; the original titration curve,
bottom; the integrated peak areas were used in curve fitting. B. Size exclusion chromatography of CaM in the absence (dashed line) and presence
(solid line) of the CnA-CBD peptide. Note the shift of the first peak (CaM) towards a larger elution volume in the presence of the peptide. The second
peak is a form of CaM appearing in CaM samples upon storage, possibly a permanently collapsed form (data not shown). The third peak is the
peptide. A(215) is shown in order to visualize the location of the peptide, which does not absorb at 280 nm. The presence of the peptide in the first
and third peaks was confirmed by SDS-PAGE (Figure S1).
doi:10.1371/journal.pone.0005402.g002
Structure of CaM-CnA Complex
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and coworkers [12] observed a very small amount of dimeric
complex under gel filtration, while it can be estimated visually
from their result that .99% was present as a monomer in the
experiment; the scale on the shown chromatogram was actually
logarithmic. Thus, at least in the absence of interactions stemming
from other parts of CnA than the CBD segment, the CaM-CnA-
CBD complex is quantitatively monomeric in solution.
Solution structure determination using small-angle X-ray
scattering
The solution properties of the complex were studied in more
detail using synchrotron small-angle X-ray scattering (Figure 3).
Scattering curves were measured for both CaM and the complex.
The SAXS data clearly indicate that the complex is monomeric (1:1
stoichiometry), as observed by comparing the values describing the
size and shape of the particle to those obtained for the CaM sample,
as well as to the theoretical values calculated from different crystal
structures using the program CRYSOL (Table 3).
Ab initio model building was also carried out for both CaM and
the complex in DAMMIN (Figure 3C,D). For the complex, the
modeled structure is clearly reminiscent of the collapsed mode of
CaM-peptide interaction, and a structure of a CaM-CaMK
Table 2. Calorimetric analysis of the CaM-CnA-CBD
interaction.
T
DH (kcal/
mol)
2TDS (kcal/
mol)
DG (kcal/
mol) Ka (1/M) Kd (mM)
+30uC 21.8 27.3 29.1 3.5610
6 0.3
+35uC 25.7 23.0 28.7 1.4610
6 0.7
doi:10.1371/journal.pone.0005402.t002
Figure 3. Small-angle X-ray scattering analysis of the solution properties of the complex. A. Scattering curve. Superposed are the curves
for CaM (blue) and the complex (red). B. Distance distribution function. Colouring as in A. Note the disappearance of the shoulder around 4.5 nm in
the presence of the peptide. The shoulder is characteristic of the dumbbell-shaped conformation of unliganded CaM, while the distance distribution
for the complex indicates a more globular shape. C. Ab initio model of CaM, with the crystal structure of unliganded CaM superimposed. D.
Superposition of the ab initio complex solution structure with the crystal structure of a canonical CaM-peptide complex (PDB code 1WRZ). E.
Superposition of the SAXS structure with half of the crystal structure of the complex. Colouring as in Figure 1A.
doi:10.1371/journal.pone.0005402.g003
Structure of CaM-CnA Complex
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Furthermore, the modeled structure apparently represents one-
half of the structure observed in the crystal structure, indicating
the presence of a collapsed 1:1 complex (Figure 3E). Between such
a complex and the crystal structure, the transformation must
involve domain swapping of the lobes of CaM (Figure 4). In the
2:2 complex, N- and C-terminal lobes from two different CaM
molecules interact with the same peptide, while in the case of the
1:1 complex, the interaction between the peptide and the lobes is
similar, but both CaM lobes come from the same molecule, and
the central helix must be bent.
Concluding remarks
We have shown here that while CaM forms a 2:2 complex with
CnA-CBD in the crystal state, the complex is of 1:1 stoichiometry,
with a collapsed conformation, in solution. The results further
highlight the plasticity of CaM in target recognition; via domain
swapping, CaM is able to bind to CnA in a 1:1 or 2:2 ratio. Our
data provide for the first time accurate 3D structural data on the
1:1 complex formed between CaM and the CnA-CBD in solution,
and unambiguously show that CaM adopts a classical collapsed
conformation upon CnA-CBD peptide binding. The observed
small hinge movement between the crystal structure and
unliganded CaM may represent an early stage of CaM collapse
around the CnA peptide, as seen in solution studies. In addition, a
novel mode of CaM target recognition has been recognized based
on our high-resolution crystallographic data, being based on a ‘1-
11’ motif, not predictable from the sequence of the CnA-CBD.
Materials and Methods
Protein and peptide preparation
Human (vertebrate) calmodulin was expressed in E. coli using
the pETCM vector as earlier described [20,21]. Briefly, CaM was
purified using calcium-dependent hydrophobic interaction chro-
matography on phenyl sepharose, concentrated using centrifugal
ultrafiltration, and dialyzed into 10 mM HEPES (pH 7.5),
100 mM NaCl, 10 mM CaCl2. The peptide corresponding to
the CaM binding domain of CnA (residues 395–411, sequence
VIRNKIRAIGKMARVFS) was purchased from GL Biochem
(Shanghai, China), dissolved in water, and dialyzed into the buffer
given above.
Isothermal titration calorimetry
Calorimetry was performed using the Microcal VP-ITC
apparatus. CaM (0.1 mM) was placed in the cell, and the CnA-
CBD peptide (1 mM) in the syringe, and injections of 5 ml were
performed. All dilutions were done with the used dialysis buffer.
The experiment was carried out in an identical fashion at
temperatures of +35 and +30uC, and the data were analyzed using
Microcal Origin. After correcting for the heat of dilution,
thermodynamic parameters for the interaction were obtained
from curve fitting of the titration data.
Size exclusion chromatography
The mobility of CaM in the presence and absence of the CnA-
CBD was analyzed by size exclusion chromatography, as
previously described for a peptide from the myelin basic protein
[9]. Briefly, CaM (200 ml at 176 mM) was run through a Superdex
75 HR 10/30 column, in the presence and absence of excess
(625 mM) CnA-CBD peptide, using 50 mM HEPES (pH 7.5),
150 mM NaCl, 4 mM CaCl2 as the running buffer. Protein
elution was followed by measuring absorbance at 215 and 280 nm,
and protein-containing fractions were analyzed by SDS-PAGE.
Crystallization and data collection
The CaM-CnA-CBD complex (10 mg/ml) was crystallized at
room temperature using the hanging drop vapour diffusion
method, with a well solution consisting of 30% PEG 400,
200 mM KCl, and 100 mM Tris (pH 8.5). The drop contained
1 ml of protein solution and 1 ml of well solution, and equilibration
was carried out over 500 ml of well solution. Prior to data
collection, the crystals were cryocooled in liquid nitrogen.
Diffraction data were collected at 100 K on the Cassiopeia
Table 3. Parameters from SAXS and comparison to theoretical values.
Sample Rg (nm) MW (kDa) Dmax (nm) Displaced volume (nm
3)
CaM (SAXS) 2.05 21.3 6 29.5
CaM+CnA-CBD (SAXS) 1.85 19.6 5.5 29.9
CaM+CnA-CBD (crystal) 2.25 38.4 7.7 47.4
CaM+CnA-CBD (half) (crystal) 1.72 18.4 5.5 22.6
1WRZ (crystal structure of a collapsed complex) 1.70 20.7 5.4 23.8
1UP5 (crystal structure of unliganded CaM) 2.29 16.7 7.0 20.4
For the SAXS samples, the molecular weight was estimated by comparing the forward scattering to that of bovine serum albumin, and the displaced volume is that of
the average ab initio model from DAMMIN. For the crystal structures, all the values have been calculated using CRYSOL.
doi:10.1371/journal.pone.0005402.t003
Figure 4. Schematic view of the transition between the two
observed complexes. Domain swapping is involved in the transition
between the 1:1 and 2:2 complex, as seen in the solution and crystal
structures, respectively. The peptides are represented by gray sticks,
and the central linker helix is shown in black. The N- and C-terminal
lobes of both CaM molecules are also labeled.
doi:10.1371/journal.pone.0005402.g004
Structure of CaM-CnA Complex
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processed with XDS [23] and XDSi [24]. 5% of all reflections
were set aside for calculating the free R factor.
Crystal structure solution and refinement
The structure was solved by molecular replacement using
Molrep [25], and the structure of the CaM-CnA-CBD fusion
protein was used as a model. Refinement was carried out in
Refmac [26], making use of TLS parameters [27,28], and model
building in Coot [29]. Water molecules were picked both
manually and using the relevant routines in Coot. The coordinates
and structure factors have been deposited at the Protein Data
Bank with the accession code 2W73.
Small-angle X-ray scattering
For SAXS, CaM and the CnA-CBD were dialyzed into a buffer
containing 50 mM HEPES (pH 7.5), 150 mM NaCl, and 10 mM
CaCl2. SAXS data for CaM in the presence and absence of the
peptide, at concentrations ranging between 1 and 10 mg/ml, were
measured on the EMBL Hamburg/DESY beamline X33, and the
corresponding buffer was always used for a blank experiment.
Programs from the ATSAS package [30] were used for data
analysis, essentially as earlier described [9,31]. The measured data
were further processed using PRIMUS [32], where the scattering
by the buffer was subtracted and the scattering normalized to a
concentration of 1 mg/ml. The molecular weight was estimated
by comparing the forward scattering I(0) to that of a standard
solution of bovine serum albumin. The distance distributions were
obtained using GNOM [33], and further used for ab initio
modelling in DAMMIN [34]. An averaged model was generated
from several runs using programs of the DAMAVER package
[35], and the SAXS model and the crystal structures were
superimposed with SUPCOMB [36]. The calculation of the
theoretical solution scattering of different crystal structures was
carried out using CRYSOL [37].
Supporting Information
Figure S1 SDS-PAGE analysis of the gel filtration fractions.
Found at: doi:10.1371/journal.pone.0005402.s001 (0.22 MB
DOC)
Table S1 DynDom analysis of domain motions between
different CaM chains
Found at: doi:10.1371/journal.pone.0005402.s002 (0.04 MB
DOC)
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